Skip to content

Compare the effects of remifentanil on EEG monitored by BIS and Narcotrend

Compare the effects of remifentanil on EEG monitored by BIS and Narcotrend

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900026874
Enrollment
Unknown
Registered
2019-10-24
Start date
2019-10-28
Completion date
Unknown
Last updated
2019-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General anesthesia depth monitor

Interventions

Case series:Different doses of remifentanil

Sponsors

Peking University Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years old; 2. American society of anesthesiologists(ASA)I-II; 3. Having general anesthesia; 4. Body mass index 18.5 to 24kg/m2.

Exclusion criteria

Exclusion criteria: 1. Allergic to anesthetics, vasoactive drugs, and other drugs or devices used in this experiment; 2. Combined with serious organ dysfunction such as heart, liver, kidney, brain and lung; 3. Patients with a history of drug abuse and a history of severe alcohol abuse; 4. Patients with central system diseases, such as cerebral infarction; 5. Taking drugs that have an effect on central nervous system function within 7 days before surgery; 6. Patients with sleep apnea syndrome.

Design outcomes

Primary

MeasureTime frame
Narcotrend index;BIS index;OAA/S score;

Secondary

MeasureTime frame
EEG, HR, SAP, DAP, SPO2;

Countries

China

Contacts

Public ContactTao Luo

Peking University Shenzhen Hospital

luotao_wh@163.com+86 13510820779

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026